BlinkAid
Wearable Device for Blink Monitoring and Prevention of Dry-eye-syndrome
Company Overview
Snapshot
Founded in November 2022 by Yechiam Sapir and Raz Karl, BlinkAid operates with 1–10 employees. The company secured seed funding in June 2023 from Galil Ofek to advance its wearable technology for dry eye and computer vision syndromes.
Business overview
BlinkAid develops a wearable application designed to prevent and alleviate the burden of Dry Eye and Computer Vision Syndromes. The company's core technology integrates into personal glasses frames, monitoring blink rate and quality. It uses highly specific and personalized neurostimulation to compensate for improper blinking, making it the first solution to utilize glasses for medical aid beyond vision correction and to address dry eye symptoms via natural blinking mechanisms. BlinkAid operates within the Health Tech & Life Sciences sector, specifically focusing on medical devices, assistive devices, and life support for patients and consumers.
Strategic signal
In September 2024, BlinkAid was featured in an article by Ynet.co.il, highlighting its innovative approach to solving dry eye syndrome without traditional liquid treatments. This media attention signals growing recognition for the company's non-invasive, wearable technology and its potential to disrupt the ophthalmology market, validating its unique value proposition to investors and the healthcare industry.
Company Intelligence Q&A
- What is BlinkAid's primary focus?
- BlinkAid focuses on developing a wearable application to prevent and alleviate Dry Eye and Computer Vision Syndromes by monitoring blink rate and quality and applying personalized neurostimulation.
- When was BlinkAid founded?
- BlinkAid was founded in November 2022 by Yechiam Sapir and Raz Karl.
- What is the core technology behind BlinkAid's solution?
- BlinkAid's core technology involves a patented system embedded into personal glasses that monitors blink patterns and uses neurostimulation to correct improper blinking, addressing dry eye symptoms through a natural mechanism.
- What recent media attention has BlinkAid received?
- In September 2024, BlinkAid was featured in an article by Ynet.co.il, which highlighted its innovative, non-invasive approach to treating dry eye syndrome.